Your browser doesn't support javascript.
loading
Alternate day treatment and late effects: the concept of an effective dose per fraction.
Courdi, A; Héry, M; Gabillat, J M.
Afiliação
  • Courdi A; Centre A. Lacassagne, Nice, France.
Int J Radiat Oncol Biol Phys ; 19(5): 1225-8, 1990 Nov.
Article em En | MEDLINE | ID: mdl-2254117
ABSTRACT
Although most institutions treat all fields each day, some radiotherapists continue to adopt an alternate day schedule. The resulting daily variations of the dose per fraction in laterally located targets have been analyzed using the linear-quadratic model. Patients with breast carcinoma treated with definitive radiotherapy in 1974-1975 with one field a day were studied. An effective dose per fraction was derived, with a value higher than the average dose per fraction received by the reference point. The greater the fluctuations between the doses per fraction on successive days, the higher the effective dose per fraction. The corresponding cell survival due to alternate treatment as compared to survival with daily treatment depends on the alpha/beta ratio. For a late effect with low alpha/beta ratio, an alternate treatment may lead to almost 10-fold increase in cell kill in these lateral targets such as those responsible for subcutaneous sclerosis as compared to daily treatment of all fields with the same total dose. Taking the average effective dose per fraction in our series, the increase in cell kill was 4-fold. Acute effects would suffer less damage due to alternate treatment because of a high alpha/beta ratio. Treatment on an alternate schedule should be restricted to palliative radiotherapy.
Assuntos
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Dosagem Radioterapêutica / Neoplasias da Mama Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Female / Humans País/Região como assunto: Europa Idioma: En Revista: Int J Radiat Oncol Biol Phys Ano de publicação: 1990 Tipo de documento: Article País de afiliação: França
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Dosagem Radioterapêutica / Neoplasias da Mama Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Female / Humans País/Região como assunto: Europa Idioma: En Revista: Int J Radiat Oncol Biol Phys Ano de publicação: 1990 Tipo de documento: Article País de afiliação: França